INSMED Inc INSM
Sales up 66.7%, free cash flow down to -$967.6M
XBRL, from each 10-KThe latest figures
Price and key numbers
All key numbers (40, from the latest 10-K and 10-Q)
- EPS (ttm)
- -2.81
- Sales (ttm)
- 1.5B
- Net income (ttm)
- -605.6M
- Sales growth
- +66.7%
- EPS growth
- -
- Sales Q/Q
- +268%
- Free cash flow
- -627.6M
- Gross margin
- 84.4%
- Oper. margin
- -37.1%
- Net margin
- -39.9%
- FCF margin
- -41.3%
- ROE
- -83.4%
- ROA
- -27.2%
- R&D / sales
- 127.2%
- Dividend
- -
- Debt/Eq
- 0.75
- Curr. ratio
- 2.86
- Cash
- 396.6M
- Op. cash flow (ttm)
- -595.6M
- EBITDA
- -1.2B
- EBITDA margin
- -203.9%
- Net debt
- 150.2M
- Quick ratio
- 2.64
- Interest cover
- -14.88
- FCF after stock pay
- -1.1B
- Goodwill / assets
- 6.0%
- Oper. margin low 5y
- -241.5%
- Stock pay / sales
- 25.2%
- Shares out.
- 219.4M
- Shares Y/Y
- +21.3%
- Book / share
- 3.31
- Cash / share
- 1.81
- Sales / share
- 6.93
- Asset turnover
- 0.68
- Inventory turns
- 0.93
- Days sales out.
- 85
- Sales 3Y CAGR
- +35.2%
- Sales 5Y CAGR
- +29.8%
- Employees
- 1,664
- Sales / employee
- 913K
Hover or tap a number to see the XBRL line item and filing it comes from; click it to open that filing at SEC. What each number means. Looks wrong? Tell us.
Revenue and net income, FY2016 to FY2025
Each fiscal year from its own 10-K · XBRL
From XBRL in each 10-K. Hover a bar for the line item and filing.
What the balance sheet holds, per share
Net current asset value and tangible book value, FY2025 · 10-K XBRL, no share price used
- + Shareholders' equity $739.0M
- − Goodwill $136.1M
- − Other intangible assets $97.7M
- = Tangible book value $505.2M
Net current asset value is current assets minus all liabilities (the long-term ones too), so it is what would be left from the short-term assets after everything owed is paid; it is blank for a bank, which reports no current assets. Tangible book value is shareholders' equity minus goodwill and other intangible assets; equity includes any preferred stock. Both are divided by the diluted weighted-average share count of the same fiscal year. Red bars are amounts taken off, or a negative result.
INSM against Health care peers
Among the 162 companies, the better end on the right. The band holds the middle half; the line is the median.
| Company | Revenue (ttm) | Sales growthFY | Gross marginttm | Net marginttm | ROEttm | FCF marginttm | Debt / equitylatest |
|---|---|---|---|---|---|---|---|
| INSM INSMED Inc | $1.5B | +66.7% | 84.4% | -39.9% | -83.4% | -41.3% | 0.75 |
| MMSI Merit Medical Systems Inc | $1.6B | +11.8% | 49.4% | 9.9% | 9.2% | 12.6% | 0.42 |
| LNTH Lantheus Holdings, Inc. | $1.6B | +0.5% | 61.3% | 17.3% | 19.9% | - | 0.42 |
| PEN Penumbra Inc | $1.6B | +17.5% | 68.0% | 10.1% | 9.9% | 12.8% | - |
| LIVN LivaNova PLC | $1.5B | +10.7% | 67.8% | 13.0% | 14.3% | 8.6% | 0.22 |
| ADUS Addus HomeCare Corp | $1.5B | +23.2% | 32.3% | 7.4% | 9.4% | 9.6% | 0.02 |
Where the $606.4M of revenue came from
by product, year to Dec 31, 2025
- ARIKAYCE $433.8M · 72%
- BRINSUPRI $172.7M · 28%
From the segment tables in the 10-K XBRL.
Where the return on equity comes from
DuPont: net margin × asset turnover × leverage, FY2025 against FY2020 · 10-K XBRL, year-end balances
The three parts multiply to the return on equity. A higher return from leverage alone means more debt or less equity (buybacks shrink equity), not a better business. Year-end balances as filed, not averages, so each number is one line of one 10-K; hover a box for its XBRL tags.
Profitability
-
Net margin below the peer median-39.9% vs 6.8%
-
Return on equity below 15%-83.4%
-
A profit in 0 of 10 years
Balance sheet
-
Interest covered less than 5 timesOperating income is -14.9× interest expense
-
Debt smaller than equityDebt / equity 0.75 on the latest balance sheet (peer median 0.69)
-
Current assets cover current liabilitiesCurrent ratio 2.86
-
More cash than debtNet cash $769.4M
Cash and shareholders
-
Free cash flow positive in 0 of 10 years−$967.6M last year
-
Share count up over 5 years+103.9%
Each tick is a fact with a fixed rule (on /methodology), not a score or advice. A check without the numbers it needs is left out.
$546.8M of principal due, schedule of Sep 30, 2026
Debt
From the balance sheet in the latest 10-K or 10-Q (XBRL). When each part falls due, year by year, and the debt note's own lines are on the Debt tab.
Income statement, balance sheet and cash flow
Statements · XBRL, each 10-K and 10-Q
INSM's income statement, balance sheet and cash flow as reported to the SEC in XBRL, one column per fiscal year, the last 10. Hover a number to see the line item and filing it comes from. Where a company changed how it tags a line, the first tag it reported for that period is used. A number looks wrong? Tell us.
Revenue by product or service
year to Dec 31, 2025| Revenue | Share | vs year before | |
|---|---|---|---|
| ARIKAYCE | 433.8M | 71.5% | +19.3% |
| BRINSUPRI | 172.7M | 28.5% | - |
10-K 0001104506-26-000009, segment and revenue notes (XBRL).
Revenue by region
year to Dec 31, 2025| Revenue | Share | vs year before | |
|---|---|---|---|
| US | 453.0M | 74.7% | +77.8% |
| International | 153.5M | 25.3% | +40.9% |
10-K 0001104506-26-000009, segment and revenue notes (XBRL).
Income statement
From EDGARBalance sheet
From EDGARCash flow
From EDGAR| FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -146.7M | -159.6M | -258.0M | -250.6M | -219.3M | -363.3M | -400.4M | -536.2M | -683.9M | -935.0M |
| Capital spending | 4.2M | 3.0M | 13.1M | 42.3M | 6.2M | 7.3M | 9.9M | 13.3M | 21.9M | 32.6M |
| Free cash flow | -150.9M | -162.6M | -271.1M | -292.9M | -225.6M | -370.6M | -410.3M | -549.5M | -705.8M | -967.6M |
| Stock-based pay (added back) | 18.0M | 18.1M | 26.2M | 27.0M | 36.2M | 46.0M | 57.7M | 74.8M | 96.8M | 152.7M |
| Free cash flow after stock pay | -168.9M | -180.7M | -297.3M | -319.9M | -261.7M | -416.6M | -468.0M | -624.3M | -802.6M | -1.1B |
| Acquisitions | - | - | - | 0 | 0 | 6.7M | 0 | 0 | - | - |
| Debt raised | 30.0M | 0 | 0 | - | - | - | - | - | - | - |
| Debt repaid | 0 | 0 | 57.8M | 0 | 0 | - | - | - | - | - |
| Investing cash flow | -4.2M | -3.0M | -14.8M | -42.3M | -6.8M | -64.3M | -34.6M | -223.6M | -583.2M | -64.6M |
| Financing cash flow | 30.7M | 381.1M | 386.7M | 285.3M | 271.0M | 612.5M | 793.3M | 168.4M | 1.3B | 954.1M |
Stock-based pay and leases
From EDGAR| FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based pay (expense) | 18.0M | 18.1M | 26.2M | 27.0M | 36.2M | 46.0M | 57.7M | 74.8M | 96.8M | 152.7M |
| Stock-based pay / revenue | - | - | 266.8% | 19.8% | 22.0% | 24.4% | 23.5% | 24.5% | 26.6% | 25.2% |
| Operating lease cost | - | - | - | 12.2M | 8.7M | 12.1M | 12.9M | 10.4M | 10.4M | 10.9M |
| Operating lease cash paid | - | - | - | 10.1M | 8.8M | 14.6M | 11.4M | 9.1M | 10.4M | 11.0M |
| Finance lease principal paid | - | - | - | 0 | 936K | 1.1M | 601K | 1.2M | 2.6M | 3.0M |
| Right-of-use assets | - | - | - | 37.7M | 32.9M | 33.3M | 21.9M | 18.0M | 17.3M | 20.7M |
| Operating lease liabilities | - | - | - | 40.3M | 32.7M | 31.0M | 21.8M | 19.0M | 18.5M | 21.6M |
| Finance lease liabilities | - | - | - | 20.8M | 15.8M | 14.7M | 30.9M | 29.6M | 27.0M | 24.1M |
From SEC's XBRL company facts (data.sec.gov). EBITDA = operating income + depreciation and amortization; free cash flow = operating cash flow - capital spending; total debt = long-term debt (with its current part) + short-term borrowings. Stock-based pay and leases are shown as the company reports them; Tickdelta does not take them out of earnings or add leases to debt. Click a number to open the filing in SEC's Inline XBRL viewer, where you can click the same number to see how it is tagged. Values a company later revised show as revised; the Revised numbers tab lists the changes.
Sources
Every figure is from the company's XBRL filed with each 10-K and 10-Q (data.sec.gov). Hover a number for its line item; click it to open the filing.
Also
Company numbers: the figures the company reports beyond the statements. Peers: ten years, side by side.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/INSM/export.csv") into a cell.